BioCryst Pharmaceuticals, Inc. BCRX
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Jonathan Wolleben | JMP Securities | 6.97 $ | 25 $ | 18.03 % | 05/11/2025 |
| Maury Raycroft | Jefferies | 6.42 $ | 15 $ | 8.58 % | 14/10/2025 |
| Gena Wang | Barclays | 7.51 $ | 7 $ | -0.51 % | 06/08/2024 |
| Maury Raycroft | Jefferies | 7.51 $ | 11 $ | 3.49 % | 05/08/2024 |
| Liisa Bayko | Evercore ISI | 12.385 $ | 16 $ | 3.62 % | 02/11/2022 |
| Gena Wang | Barclays | 14.325 $ | 14 $ | -0.32 % | 23/08/2022 |
| Ken Cacciatore | Cowen & Co. | 14.78 $ | 25 $ | 10.22 % | 10/01/2022 |
| Brian Cheng | Cantor Fitzgerald | 12.4 $ | 21 $ | 8.60 % | 03/11/2021 |
| Maury Raycroft | Jefferies | 17.65 $ | 19 $ | 1.35 % | 09/08/2021 |